» Articles » PMID: 23915977

MiR-125b, MiR-100 and MiR-99a Co-regulate Vincristine Resistance in Childhood Acute Lymphoblastic Leukemia

Overview
Journal Leuk Res
Date 2013 Aug 7
PMID 23915977
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNA-125b (miR-125b), miR-99a and miR-100 are overexpressed in vincristine-resistant acute lymphoblastic leukemia (ALL). Cellular viability of ETV6-RUNX1-positive Reh cells significantly increased in presence of 9 ng/mL vincristine upon co-expression of miR-125b/miR-99a (91 ± 4%), miR-125b/miR-100 (93 ± 5%) or miR-125b/miR-99a/miR-100 (82 ± 17%) compared with miR-125b-transduced cells (38 ± 13%, P<0.05). Co-expression of these miRNAs resulted in downregulation of DNTT, NUCKS1, MALAT1, SNRPE, PNO1, SET, KIF5B, PRPS2, RPS11, RPL38 and RPL23A (fold-change 1.3-1.9, p<0.05). Similarly, 7 out of these genes are lower expressed in vincristine-resistant ALL cells of children (p<0.05). The concerted function of miR-125b in combination with miR-99a and/or miR-100 illustrates the complexity of vincristine-resistant pediatric ALL.

Citing Articles

miR‑100: A key tumor suppressor regulatory factor in human malignant tumors (Review).

Zhang L, Zhang J, Zhang X, Liu S, Qi C, Gao S Int J Mol Med. 2025; 55(4).

PMID: 40017111 PMC: 11875724. DOI: 10.3892/ijmm.2025.5508.


Ribosome Biogenesis and Cancer: Insights into NOB1 and PNO1 Mechanisms.

Ragunath M, Shen A, Wei L, Peng J, Thiruvengadam M Curr Pharm Des. 2024; 30(37):2911-2921.

PMID: 39143880 DOI: 10.2174/0113816128301870240730071910.


Aberrant stem cell and developmental programs in pediatric leukemia.

Ling R, Cross J, Roy A Front Cell Dev Biol. 2024; 12:1372899.

PMID: 38601080 PMC: 11004259. DOI: 10.3389/fcell.2024.1372899.


The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.

Barrios-Palacios D, Organista-Nava J, Balandran J, Alarcon-Romero L, Zubillaga-Guerrero M, Illades-Aguiar B Int J Mol Sci. 2024; 25(1).

PMID: 38203290 PMC: 10779195. DOI: 10.3390/ijms25010119.


miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia.

Tsotridou E, Georgiou E, Tragiannidis A, Avgeros C, Tzimagiorgis G, Lambrou M Oncol Lett. 2024; 27(2):71.

PMID: 38192661 PMC: 10773203. DOI: 10.3892/ol.2023.14204.